Detalhe da pesquisa
1.
Everolimus with cyclosporine withdrawal or low-exposure cyclosporine in kidney transplantation from Month 3: a multicentre, randomized trial.
Nephrol Dial Transplant
; 32(6): 1060-1070, 2017 Jun 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28605781
2.
Fast onset of action of glycopyrronium compared with tiotropium in patients with moderate to severe COPD - A randomised, multicentre, crossover trial.
Pulm Pharmacol Ther
; 42: 13-20, 2017 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-27940287
3.
Early conversion from cyclosporine to everolimus following living-donor kidney transplantation: outcomes at 5 years posttransplant in the randomized ZEUS trial.
Clin Nephrol
; 85(4): 215-25, 2016 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-26932178
4.
Renal, efficacy and safety outcomes following late conversion of kidney transplant patients from calcineurin inhibitor therapy to everolimus: the randomized APOLLO study.
Clin Nephrol
; 83(1): 11-21, 2015 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-25512099
5.
Efficacy and safety of conversion from cyclosporine to everolimus in living-donor kidney transplant recipients: an analysis from the ZEUS study.
Transpl Int
; 27(11): 1192-204, 2014 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-25070687
6.
Everolimus in patients with autosomal dominant polycystic kidney disease.
N Engl J Med
; 363(9): 830-40, 2010 Aug 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-20581392
7.
A randomized trial of intensified vs. standard dosing for enteric-coated mycophenolate sodium in de novo kidney transplant recipients: results at 1 year.
Clin Nephrol
; 79(6): 421-31, 2013 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-23611518
8.
BK viremia and polyomavirus nephropathy in 352 kidney transplants; risk factors and potential role of mTOR inhibition.
BMC Nephrol
; 14: 207, 2013 Oct 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-24088187
9.
Positive effects of zoledronate on skeletal-related events in patients with renal cell cancer and bone metastases.
Can J Urol
; 19(3): 6261-7, 2012 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-22704310
10.
Bone turnover markers as predictive tools for skeletal complications in men with metastatic prostate cancer treated with zoledronic acid.
Prostate
; 69(6): 624-32, 2009 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-19143027
11.
Octreotide LAR and Prednisone as Neoadjuvant Treatment in Patients with Primary or Locally Recurrent Unresectable Thymic Tumors: A Phase II Study.
PLoS One
; 11(12): e0168215, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-27992479
12.
The MANDELA study: A multicenter, randomized, open-label, parallel group trial to refine the use of everolimus after heart transplantation.
Contemp Clin Trials
; 45(Pt B): 356-363, 2015 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-26363128
13.
The ZOTECT study: Effect of zoledronic acid on bone metabolism in patients with bone metastases from prostate or breast cancer.
J Bone Oncol
; 1(3): 88-94, 2012 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-26909262